Preventing Medication Mismanagement in People Living With Dementia

Part of paid clinical trials in Folsom, California.

Sponsor
HiDO Technologies
Study ID
NCT07600684
Status
Recruiting
Apply to this trial

Conditions

  • Dementia

Eligibility Criteria

Sex
ALL
Age
65 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • HiDO HomeCareSystem — DEVICE
    Participants randomized to the intervention arm will receive and be trained on the HiDO HCS Device and will have medication dispensed via this technology.

Study Details

The purpose of this research is to learn whether the HiDO-ALZ device can improve medication compliance and health outcomes in participants with dementia that need to take daily medication.

Key Dates

Start date
May 5, 2026
Status verified
May 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
50 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Active Comparator: HiDO HomeCare System
    The HiDO HomeCare System (HCS) is a medication dispensation device that participants will interface with via face recognition at the time they are expected to take medication. HCS is tool that can assist participants and their care partners remember and monitor medication dosing.
  • No Intervention: Standard Medication Management
    Participants randomized to Standard Medication Management will continue taking medication as usual, without the assitance of the HiDO HCS.

Primary Outcome Measure

Change From Baseline to 12 months in Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) Total Score [ Time Frame: baseline and 12-months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
HiDO TechnologiesFolsomCalifornia95762
Charles Gellman
[email protected]
5138137224
Lisa Marceau
[email protected]
4014284197
Charles Gellman (PRINCIPAL_INVESTIGATOR)

Find similar trials in Folsom, CA

By research site
HiDO Technologies· Folsom, CA

Related Studies